Novartis, Edouard-Marcel Sandoz
The Ferrari deal is expected to be the largest of a clutch of block trades this week, including a Sfr2.6bn (€2.8bn) block in ...
Swiss generic drug manufacturer Sandoz has agreed to pay $275 million to resolve claims by U.S. consumers and others who ...
Swiss generics and biosimilars major Sandoz has announced the launch of Pyzchiva (ustekinumab-ttwe) in the USA. From today, ...
Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing RulesKey biosimilar value driver contributes to Sandoz global growth strategy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results